January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability to automate complex workflows and enhance productivity is seen as a ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.

After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.